[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625141":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":57,"collaborators":59,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":10,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":10,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Participants with Meningioma",null,"Adult patients who have been diagnosed with a meningioma will be asked to complete a one-time survey, which will take roughly 20 minutes to complete. Participants will also have medical records reviewed to capture additional data relating to the participants medical history.",[13,14],"Behavioral: Questionnaire","Other: Medical Record Review",[16,21],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"BEHAVIORAL","Questionnaire","A questionnaire will be administered in person or online",[9],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"Medical Record Review","Medical records will be reviewed for study specific data collection",[9],[26],{"name":27,"affiliation":28,"role":29},"David Raleigh, MD, PhD","University of California, San Francisco, San Francisco, California 94143","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},"Zora Arum","CONTACT","877-827-3222","zora.arum2@ucsf.edu",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"University of California San Francisco","RECRUITING","San Francisco","California","94143","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-122.41942,37.77493,{"lat":49,"lon":48},[52,53,55],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},{"name":10,"role":33,"phone":34,"phoneExt":10,"email":54},"cancertrials@ucsf.edu",{"name":56,"role":29,"phone":10,"phoneExt":10,"email":10},"David Raleigh, MD PhD",{"type":58,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[60],{"name":61,"class":62},"National Cancer Institute (NCI)","NIH","100625141","tumor-genomics-individual-risk-factors-and-external-drivers-of-health-on-health-outcomes-for-patients-with-meningioma-100625141",false,"NCT07418775","Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma","An Investigation of Tumor Genomics, Individual Risk Factors, and External Drivers of Health to Improve Health Outcomes for Patients With Meningioma","Inclusion Criteria:\n\n* Adults ≥18 years of age\n* Able to speak and read English\n* Diagnosed with a meningioma\n\nExclusion Criteria:\n\n* Active psychiatric issues (suicidality, active psychosis, grave disability, etc.)\n* Inability to consent secondary to severe neurologic deficit or psychiatric distress\n* Inability to complete survey secondary to severe neurologic deficit or psychiatric distress",true,"ALL","18 Years",{"count":74,"type":75},3000,"ESTIMATED","OBSERVATIONAL","Meningiomas are the most common primary brain tumor, and some groups are diagnosed with higher-grade tumors and have clinically worse outcomes. This study investigates social determinants of health and individual risk factors that may be associated with meningioma.",[79,80,81],"Meningioma of Brain","Meningioma","Brain Tumor","2026-05-15",{"date":84,"type":85},"2026-05-19","ACTUAL",{"date":87,"type":85},"2026-01-16",{"date":89,"type":75},"2032-01-01",{"name":5,"class":6},1]